Avera Health Partners with Elekta
Avera Health has announced a new partnership with Elekta, a technology company specializing in cancer treatment. Under the agreement, Avera will deploy Elekta’s MOSAIQ oncology information system across the Avera Cancer Institute.
According to Avera, the new partnership will enable the Cancer Institute to implement an integrated oncology health system that spans the full cancer care continuum, from prevention and screening through to palliation and recovery.
The agreement includes Elekta linear accelerators (Versa HD, Elekta Infinity), Leksell Gamma Knife Perfexion and brachytherapy solutions Monaco treatment planning and METRIQ cancer registry software. All of the software will be deployed through a cloud-based solution.
“By choosing Elekta as our partner, we will be able to give our patients access to the world’s most advanced technology for treating cancer,” says Michael Peterson, MD, Radiation Oncologist with Avera Health. “Having both Versa HD and Perfexion provides superior capabilities for stereotactic treatment delivery, enabling us to perform treatments faster, with even greater precision.”
“Through this partnership, Avera will be able to access a single patient record at any of our cancer centers and outreach locations,” says Dave Flicek, Chief Administrative Officer for Avera Medical Group: This ensures connectivity between cancer providers, chemotherapy, and radiation therapy centers and cancer registries.”